EE416 Cost-Effectiveness of Sulbactam-Durlobactam Compared to Colistin in Treating Carbapenem-Resistant Acinetobacter Baumannii Infections in Critical Care Setting in the United States: A Decision Analysis
Abstract
Authors
A Ologunowa AR Caffrey S Kogut